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Functional characterisation of proteins and large-scale, systems-level studies are enabled by extensive
sets of cloned open reading frames (ORFs) in an easily-accessible format that enables many different
applications. Here we report the release of the ﬁrst stage of the Xenopus ORFeome, which contains 8673
ORFs from the Xenopus Gene Collection (XGC) for Xenopus laevis, cloned into a Gateways donor vector
enabling rapid in-frame transfer of the ORFs to expression vectors. This resource represents an estimated
7871 unique genes, approximately 40% of the non-redundant X. laevis gene complement, and includes
2724 genes where the human ortholog has an association with disease. Transfer into the Gateway system
was validated by 5′ and 3′ end sequencing of the entire collection and protein expression of a set of test
clones. In a parallel process, the underlying ORF predictions from the original XGC collection were re-
analysed to verify quality and full-length status, identifying those proteins likely to exhibit truncations
when translated. These data are integrated into Xenbase, the Xenopus community database, which as-
sociates genomic, expression, function and human disease model metadata to each ORF, enabling end-
users to search for ORFeome clones with links to commercial distributors of the collection. When cou-
pled with the experimental advantages of Xenopus eggs and embryos, the ORFeome collection represents
a valuable resource for functional genomics and disease modelling.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Xenopus is a powerful vertebrate model system for investigat-
ing protein function and it has a rich history of functional geno-
mics (Harland and Grainger, 2011). There are currently two
members of the genus used for biomedical research: the earlier
adopted, allotetraploid Xenopus laevis, and its slightly smaller
cousin Xenopus tropicalis, which has a normal diploid DNA com-
plement. Both species are widely used, and share the key char-
acteristic of large, abundant, externally developing eggs and em-
bryos, making them ideally suited for the discovery and analysis of
protein function. For example, many well-known developmental
regulators such as Noggin (Smith and Harland, 1992) and Dickkopf
(Glinka et al., 1998) were ﬁrst identiﬁed by functional screening
of synthetic mRNA from cDNA libraries injected into Xenopusr Inc. This is an open access article
E. Hill),embryos. Moreover, essential cell cycle regulators such as INCENP
(Stukenberg et al., 1997), Securin (Zou et al., 1999), Geminin
(McGarry and Kirschner, 1998) and Sororin (Rankin et al., 2005)
were identiﬁed and characterized using functional screens in Xe-
nopus extracts. A key reagent for these types of screens and the
analysis of protein function in Xenopus are high quality cDNA
libraries.
Over the last decade there were two major efforts to gen-
erate large-scale cDNA collections with high diversity and low
redundancy as resources for the community: the NIH-spon-
sored IMAGE Consortium Xenopus Gene Collection (XGC), in
collaboration with the Joint Genome Institute and many in-
dividual labs (Klein et al., 2002); and the Wellcome Trust-fun-
ded X. tropicalis EST sequencing project run jointly by the
Sanger and Gurdon Institutes in the UK (Gilchrist et al., 2004).
These projects took similar approaches by performing large
scale sequencing on diverse cDNA libraries followed by com-
putational identiﬁcation of full-length clones and re-arraying
to create non-redundant full-length collections (reviewed
in Gilchrist (2012)). Clones from both projects were madeunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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I.M. Grant et al. / Developmental Biology 408 (2015) 345–357346available through commercial distributors, and have clearly
inﬂuenced ongoing research efforts using this model system:
they are currently cited in PubMed Central in 52 and 49 articles
respectively. Although these resources continue to be useful,
the rate-limiting step in contemporary research can often be
subcloning of the open reading frames (ORFs) into different
types of expression plasmids (e.g. CMV or SP6 promoters) with
the appropriate epitope tags (e.g. GFP, ﬂag, etc.) for the many
different types of functional experiments that researchers
perform. To address this need, and facilitate functional geno-
mics in Xenopus, we therefore set out to generate an ORFeome
(Brasch et al., 2004) for the Xenopus model system, comprising
a large collection of Xenopus ORFs in a Gateway-compatible
vector (Hartley et al. (2000); Walhout et al., 2000) that enables
rapid and easy transfer to many different plasmids using the
bacterial recombination system.
A Gateway-based ORFeome is designed to streamline the
generation of cDNA clones amenable to use for high-throughput
expression of protein, including the removal of untranslated
regions, mutation of the stop codon (in order to generate 3′
fusion proteins), and engineering 5′ and 3′ ends so that they
have suitable restriction or recombineering sequences. Moving
the cDNA into a general purpose Gateway entry vector has the
added utility that the clone can subsequently be easily moved
into a variety of destination vectors with distinct uses. The
Gateway system utilises the bidirectional, site-speciﬁc re-
combination of bacteriophage λ; the in vitro reactions are ef-
ﬁcient, offer nucleotide precision, and enable large-scale auto-
mation of unidirectional cloning of ORFs into a wide array of
plasmids for functional experiments. ORFs in Gateway entry
constructs can be transferred between vectors in a matter of
hours, rather than the 2–3 days typically required by conven-
tional cloning methods. Different types of destination vector
allow expression of ORFs in bacteria, eukaryotic cells, or, in the
case of the pCS2 family of vectors, enable the production of
synthetic mRNA for injection into Xenopus oocytes and embryos
(Rupp et al., 1994). Destination vectors are also frequently used
to enable the addition of N- or C-terminal fusions such as green
ﬂuorescent protein (GFP) or small epitope tags (e.g. HA or Flag).
ORFeomes using the Gateway recombination cloning system
have previously been constructed for a range of species, in-
cluding: human (Lamesch et al., 2007; Rual et al., 2004; Yang
et al., 2011), Caenorhabditis elegans (Reboul et al., 2003), Sac-
charomyces cerevisiae (Gelperin et al., 2005), Brucella melitensis
(Dricot et al., 2004), Chlamydophila pneumoniae (Maier et al.,
2012), Staphylococcus aureus (Brandner et al., 2008), Escherichia
coli (Rajagopala et al., 2010), as well as being partially available
for Drosophila melanogaster (Bischof et al., 2013), and mouse
(Temple et al., 2009). See Table 1 for a summary of methods and
coverage.
The development of a Xenopus ORFeome is an important part
of keeping the research capabilities of this model system up to
date, and will enable researchers to create the right tools to do
this. Although protein function is often conserved, scientiﬁc
rigour requires that Xenopus experiments are performed with
Xenopus proteins. Proteins co-evolve, and the necessary tight
interactions between species-speciﬁc proteins may be less ef-
fective between proteins that have evolved separately. In ad-
dition this is an opportunity to generate an ORFeome where
every ORF has been analysed for completeness and the analysis
is transparently presented. Furthermore, the data generated in
the production of the ORFeome will improve our deﬁnition of
the transcriptome and hence the annotation of gene loci on the
genome; these will be integrated into Xenbase, the Xenopus
community database (Bowes et al., 2008; Karpinka et al., 2014).
This project has two phases: the ﬁrst phase will take advantage
I.M. Grant et al. / Developmental Biology 408 (2015) 345–357 347of the existing full-length cDNA resources for each Xenopus spe-
cies, and the second phase will apply a more experimentally in-
tensive, RT-PCR based method using predicted ORFs. Phase one
will proceed in two stages, starting with the X. laevis clones from
the XGC collection (which we are currently releasing, and describe
here), before moving on to the X. tropicalis clones from both the
XGC and Wellcome/Sanger collections. This order is determined in
part by practical considerations, as the XGC X. laevis collection
covers more genes than either of the X. tropicalis collections
(Gilchrist, 2012), and because X. laevis is currently the more widely
used of the two frog model species, and was therefore set as the
ﬁrst priority by the community.Fig. 1. Schematic overview of generation of the Xenopus ORFeome, v1.0. (a) PCR primers
EST sequenced at 5′ and 3′ ends, and these sequences were BLASTed against the XGC ORF
bare ORF in a Gateway entry construct. (d) 8673 Gateway entry clones were consolidate
v1.0. (e) Imunoblots of 17 proteins after transfer from Xenopus ORFeome Gateway entry v
different proteins act as internal controls for each other in this experiment, success is in
(Bio-Rad). Weights are given in kDa, and include 36 kDa for the LAP tag (GFP-TEV-S) fusi
post-translational modiﬁcations.Here we describe the generation and validation of the Xenopus
ORFeome, version 1.0, which contains 8673 X. laevis ORFs from the
NIH Xenopus Gene Collection (XGC) (http://xgc.nci.nih.gov/) (Klein
et al., 2002), and includes 2724 genes where the human ortholog
has an association with disease. The Xenopus ORFeome collection
will transform the ability of the community both to rapidly char-
acterize protein function, and to screen for novel activities in this
highly effective disease model. The ORFeome collection will be
made available to the community through a number of dis-
tributors, and may be purchased as individual clones or complete
sets. Information on the Xenopus ORFeome collection can be found
at http://www.xenbase.org/reagents/static/orfeome.jsp.were designed to 9805 ORFs from the XGC cDNA library. (b) The PCR products were
s. (c) BP recombination cloning reaction with the donor vector, pDONR223 gives the
d based on conﬁrmation of identity from sequencing to produce Xenopus ORFeome
ectors into a C-terminal GFP-tagged destination vector after in vitro translation. The
dicated by the relative positions of bands of predicted size, compared to standards
on. Faint bands may be caused by ribosomes starting at incorrect start sites, or from
I.M. Grant et al. / Developmental Biology 408 (2015) 345–3573482. Materials and methods
2.1. Gateway cloning of X. laevis open reading frames from the Xe-
nopus Gene Collection
The Xenopus Gene Collection (XGC) resource (Klein et al., 2002)
is made available through the IMAGE Consortium network (http://
xgc.nci.nih.gov/), and for X. laevis comprises 104 96-well plates
containing 9984 putatively full-length cDNA clones. From a copy of
this we extracted 9805 viable cDNA clones, which therefore
comprised our starting material. The original clones were collected
containing both coding sequence and 5′ and 3′ untranslated re-
gions (UTRs), and the XGC reference open reading frames varied in
length from 75 bp to 7.5 kb. We attempted to clone all the avail-
able ORFs for which we had viable starting material.
The strategy for cloning the ORFs from the XGC cDNA library
into Gateway entry vectors for the Xenopus ORFeome (see Fig. 1) is
identical to that developed for use in the human ORFeome, version
1.1 (Rual et al., 2004). Brieﬂy, this involves polymerase chain re-
action (PCR) ampliﬁcation of the open reading frame portion of an
XGC cDNA clone using a pair of ORF-speciﬁc primers for each
clone. Primers were designed from the set of XGC reference ORFs
as supplied. Forward primers were designed from the ﬁrst base of
the start codon, and reverse primers were designed from the last
base preceding the stop codon, omitting the stop codon from
subsequent Gateway constructs. Forward and reverse ORF-speciﬁc
primers were extended with Gateway attB1 and attB2 sites, re-
spectively, to facilitate easy recombination cloning via a Gateway
BP reaction with pDONR223 as described (Rual et al., 2004).
Plasmids were introduced into chemically competent DH5α bac-
teria, selecting for spectinomycin resistance.
2.2. Clone sequencing and consolidation
PCR products from the Gateway clones were Sanger-sequenced
from both ends to generate 5′ and 3′ expressed sequence tags
(ESTs) (Reboul et al., 2001). An existing software pipeline (Lamesch
et al., 2007; Reboul et al., 2001; Rual et al., 2004) was used to
verify that the cloned ORF contained the expected sequence: ESTs
were aligned against a database of the reference ORF coding se-
quences from the XGC set, and the best hit recorded for each EST.
An ORF was considered to have been successfully cloned if at least
one of the ESTs matched the reference sequence with a BLAST
score (Altschul et al., 1990) of 50 or more. Successful clones were
consolidated into a new array of 93 96-well plates to form the
Xenopus ORFeome, version 1.0.
2.3. Validation of Gateway transferability of Xenopus ORFeome
clones
Twenty ORFs of various molecular weights and functions, that
passed the Gateway cloning QC criteria for inclusion in the Xenopus
ORFeome v1.0 collection, were transferred from their Gateway entry
vectors via an LR reaction into the pCSf107mT-Gateway-3′LAP des-
tination vector (see following), which contains a green ﬂuorescent
protein (GFP) tag at the C-terminal end of the ORF. Following LR
transfer, clone identity and in-frame transfer were conﬁrmed by
Sanger sequencing. Three clones failed at this stage. Sequence-con-
ﬁrmed clones were then expressed in a coupled, in vitro transcription
and translation reaction in reticulocyte lysate, and the product
identiﬁed by immunoblot using anti-GFP antibodies.
2.4. Generation of the pCSf107mT-Gateway-3′LAP tag vector
A LAP tag contains enhanced green ﬂuorescent protein (eGFP)
followed by a tobacco etch virus (TEV) protease site and an S-tagfor afﬁnity puriﬁcation (Raines et al., 2000). The LAP tag from the
pIC113 vector (Cheeseman and Desai, 2005) was sub-cloned into
the pcDNA5.0/FRT vector (Invitrogen) using the Xho I site to
generate the pcDNA5.0/FRT-LAP-N vector. The CmR-ccdB cassette
from the pDONR221 vector was ampliﬁed via PCR and inserted
upstream of the LAP tag of the pcDNA5.0/FRT-LAP-N vector using
the Kpn I site to make the DLAP-C vector. To make the pCSf107mT-
Gateway-3′LAP destination vector, the CmR-ccdB cassette and LAP
tag from the DLAP-C vector was ampliﬁed via PCR and inserted
into the pCSf107mT vector (Mii and Taira, 2009) using the Bgl II
and Xho I sites. Plasmids containing this destination vector (and
three others: pCSf107mT-Gateway-3′ Flag, pCSf107mT-Gateway-3′
3xHA and pCSf107mT-Gateway-3′ Myc) may be obtained from
Addgene (www.addgene.org) under the IDs 67616, 67617, 67618
and 67619.
2.5. Tests for computational veriﬁcation of the XGC reference ORFs
Using the NCBI BLASTþ alignment tool (Camacho et al., 2009),
the full cDNA sequence of each XGC cDNA clone, including the 5′
and 3′ UTRs, was aligned to cluster consensus sequences from the
X. laevis full-length EST database (Gilchrist et al., 2004) (http://
genomics.nimr.mrc.ac.uk/online/xt-ﬂ-db.html, assembly Xl4). To
ﬁnd the correct homeolog we noted the best-matching EST cluster
for each XGC cDNA, using a percent identity match cut-off of 95%
and ordering the alignments by start coordinate on the reference
sequence and then BLAST bit-score. Where there were no suitable
matches, we ran a second search using a lower percent identity
cut-off (80%) to ﬁnd a match with the alternate homeolog.
The NCBI BLASTX tool was used to ﬁnd the best matching
protein for each XGC cDNA clone from each of six selected non-
Xenopus species: human (Homo sapiens), mouse (Mus musculus),
chicken (Gallus gallus), zebraﬁsh (Danio rerio), worm (S. cerevisiae),
and ﬂy (D. melanogaster). Averaging over these alignments, the
relative position on the XGC cDNA sequence of the predicted
N-terminus of a conserved protein was calculated (Fig. 2a). These
data were then combined to score each reference ORF according to
a series of tests (Table 2).
An additional pair of tests was created by taking short (96 bp)
sequence tags from both the start of the XGC reference ORF, and
from successive in-frame ATG positions within the open reading
frames deﬁned in the assembled EST contigs described above.
These latter are labelled ATG1, ATG2, etc., and are then re-labelled
using the full-length scores with positional information associated
with these assemblies, in particular the BLH/ATG score (Gilchrist
et al., 2004) indicating the most likely ATG to be a conserved start
of translation from a basket of species' proteins, and the EST/CLI, or
cliff, score (Gilchrist et al., 2015) indicating the likely start of
transcription. If the position of the BLH/ATG score is at the position
of a tag labelled ‘ATG1’, the tag is re-labelled ‘ORF’, or if it is at the
position of a higher number ‘ATGn’ (n 9≤ ) it is re-labelled ‘CONS’
(conserved); scores below 10 are ignored. If the position of the
EST/CLI score is before, or within 12 bp, in the 3′ direction, of a tag
labelled ATG1, then the tag is re-labelled ‘CLI’; ‘ORF’ is preferred
over ‘CLI’. The XGC reference tags are then matched with all the
EST contig tags to ﬁnd the best match, with at least 80% similarity,
and the label on the EST tag is used to evaluate the XGC ORF. La-
bels ‘ORF’, ‘CONS’, CLI’ and ‘ATG1’ indicate a full-length or con-
served N-terminus protein; conversely, labels ‘ATG2’, ‘ATG3’, etc.
indicated a truncated protein.
The ORFs were then grouped into ﬁve categories according to
the sum of these tests (Table 3). A positive tag test ‘CONS’, in-
dicating a conserved N-terminus within a slightly truncated open
reading frame, is used to over-ride negative test indications.
Fig. 2. Testing the full-length status of the XGC ORFs (a) using protein alignment: translated protein alignments to non-Xenopus species yields a predicted position for the start
codon on a zero-based scale running from 5′ to 3′ along the length of the cDNA sequence. The position of the XGC-deﬁned start codon on the clone cDNA sequence is marked as
A. The start of conserved protein alignment on the XGC cDNA sequence is labelledC , and P is the predicted position of the start codon based on the length of the protein
sequence, i.e. P C c= − , where c is the position of the start of conservation on the non-Xenopus protein sequence. The minimum possible value of C is zero, but P can be
negative. For each XGC ORF, P and C were averaged over all the respective homologous protein alignments to produce single, average values for P¯ and C¯ , respectively.
(b) Analysis of the XGC ORFs, over all tests, predicts 85% of the Xenopus ORFeome v1.0 to be full-length (89% including conserved ORFs, see Section 2). (c) Frequency distribution
of open reading frame lengths in the source XGC cDNA library and the consolidated Xenopus ORFeome collection, showing equal likelihood of cloning long and short ORFs.
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Table 2
Tests of full-length validity were applied to each of the XGC ORFs. If a clone ﬁts the criteria, the score is þ1 for that test; otherwise the score is 0. The sufﬁx .p denotes a
positive test, i.e. ﬁtting the criteria for such a test is a positive indicator for the ORF being truly full-length; .n denotes a negative test – matching these tests indicates the ORF
may not be full-length. See Fig. 2a for deﬁnitions of C P A, , .
Test Description
1.p ATG word correct The ATG word (12 bases at the beginning of the ORF) on the XGC cDNA matches that from the best-hit EST cluster.
2.p P A¯ ≈ The average predicted start codon position on the cDNA from non-Xenopus protein alignments (P¯ ) is within 12 bp of that
deﬁned by the XGC ORF ( A).
3.p P A 2∑ ( ≡ ) ≥ If at least two separate, individual protein alignments from non-Xenopus species give P A= exactly, then this is good
evidence of veracity, due to low probability of this occurring by chance.
4.p Positive tag match The 96 bp tag from the start of the XGC ORF matches a similar tag from the Xl4 EST assembly marked ORF, CONS, CLI, or
ATG1, implying that the XGC start codon matches the start of the open reading frame or a conserved N-terminus
translation.
5.n ATG codon upstream in 5′ UTR matches
EST
The EST and cDNA ATG words do not match. When the sequences are aligned, the relative position of the EST start codon
is upstream of the cDNA start codon. This means that the cDNA start codon matches another ATG codon downstream of
that deﬁned as the start codon on the EST cluster sequence, i.e. the cDNA ORF is truncated with respect to the EST ORF at
the 5′ end. In this case, an upstream ATG codon in the 5′ UTR of the cDNA matches that deﬁned as the start codon on the
EST, i.e. this is possible evidence that the XGC ORF has been incorrectly deﬁned using a downstream ATG codon.
6.n C
P
0
0
¯ ~
¯ ≪
Protein conservation includes the 5′ UTR of the XGC cDNA sequence (C 15¯ < or A 2 where the 5′ UTR is very short), but the
typical length of the conserved protein is longer, resulting in a negative value for P¯ (we used a cut-off of P 15max < − or
P 15Pσ¯ + < − ) indicating that the full cDNA sequence (ORFþ5′ UTR) is truncated at the 5′ end.
7.n Negative tag match The 96 bp tag from the start of the XGC ORF matches a similar tag from the Xl4 EST assembly marked ATG2, ATG3, or
greater (up to ATG9) implying that the XGC start codon matches an in-frame ATG partway into the open reading frame,
and is not likely to represent a conserved N-terminus translation.
I.M. Grant et al. / Developmental Biology 408 (2015) 345–3573502.6. Application of Xenbase gene annotation to the XGC ORFs
Using the NCBI BLASTþ tool, the XGC open reading frames
were matched to mRNA sequences provided by the Xenopus
community database resource, Xenbase, which have pre-existing
stable Xenbase gene IDs assigned to them (Bowes et al., 2008;
Karpinka et al., 2014). Mapping tables were also provided by
Xenbase to associate gene names and symbols to the IDs. Another
Xenbase mapping table groups individual genes together under an
umbrella gene ID where they are known to be homeologs of one
another in X. laevis, or orthologs of the related gene in X. tropicalis.
(Genes may generally be duplicated in the allotetraploid X. laevis
compared to the diploid X. tropicalis, and these duplicated genes
are referred to as homeologs.)
2.7. Human disease gene orthology
To establish relationships between the ORFeome clones and
human disease-associated genes, we took data from a number of
sources. First we downloaded the list of human genes linked to
disease phenotypes from the Online Mendelian Inheritance in Man
database (OMIM, http://omim.org); these were linked through the
MIM gene IDs reported on Xenbase gene pages to Xenopus mRNA
sequences, and these were linked via BLAST similarity to the XGC
reference sequence associated with each ORFeome clone. This
created a set of direct associations between human disease genes
and their Xenopus orthologs. In addition we downloaded data from
a published, large-scale database of inferred human proteinTable 3
The XGC clones were classiﬁed according to our predictions as to the veracity of their O
Full-length status Deﬁnition from test scores Description
Good i p i n. 0, . 0i i1
4
5
7∑ > ∑ == =
At least one of the positive tests wa
full-length.
Conserved p tag4. 1, CONS= = Test 4.p applies (scores þ1), and th
will override other negative tests. E
Mixed i p i n. 0, . 0i i1
4
5
7∑ > ∑ >= =
Passed at least one positive test, bu
data are inconclusive.
Bad i p i n. 0, . 0i i1
4
5
7∑ = ∑ >= =
The clone passed none of the positi
based on comparison with EST and
Unknown i p i n. 0, . 0i i1
4
5
7∑ = ∑ == =
No tests were passed or failed; thecomplexes (Lage et al., 2008), where each complex contained
at least one gene–disease link from OMIM. Proteins in these
disease-associated complexes, but without a direct link to OMIM,
were considered to have an indirect association with the disease or
diseases associated with each complex. The data downloaded from
this source comprised MIM disease phenotypes, Ensembl human
protein IDs and protein complex identiﬁers; these were linked via
Ensembl/NCBI-Entrez ID conversions, downloaded from Biomart,
to the Entrez ID of the human ortholog stored on Xenbase
gene pages, and then linked as above from the Xenopus mRNAs to
the ORFeome clones. The union of these two datasets was used
to identify human disease orthology within the Xenopus
ORFeome, and in addition we recorded whether the gene-disease
association was direct (via OMIM) or indirect (via Lage et al.
(2008)).3. Results and discussion
3.1. Generation of the Gateway-compatible X. laevis ORFeome
collection
In order to generate the ﬁrst version of the Xenopus ORFeome,
we took advantage of the Xenopus Gene Collection (XGC) resource
(http://xgc.nci.nih.gov/), a trans-NIH initiative that collated a set of
9984 putatively full-length X. laevis cDNA clones from a number of
cDNA libraries derived from different tissues and developmental
stages produced as part of the Xenopus EST project (Klein et al.,RFs based on the sum of scores from the tests deﬁned in Table 2.
s passed, and none of the negative tests were failed; the ORF is highly likely to be
e tag type (‘CONS’) indicates the presence of a conserved ATG (N-terminus); this
ven though the ORF is technically truncated the protein is likely to be functional.
t also failed at least one negative test; the ORF is probably still full-length, but the
ve tests and failed at least one of the negative tests; the ORF is likely to be wrong
conserved protein data.
data are insufﬁcient to determine whether the ORF is full-length or not.
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3′ untranslated regions (UTRs).
We were aware at the start of the project, given an earlier
analysis of part of the X. tropicalis XGC clone data (Gilchrist, 2012),
that there may be errors in the X. laevis XGC reference ORFs.
However, as the funding for the Xenopus ORFeome was based in
part on a mandate from the community as the highest ranked
immediate need in the 2011 Xenopus White paper (http://www.
xenbase.org/community/static/xenopuswhitepaper/2011/XWP_
xenbase.pdf), we felt it was important to make a prompt start with
the cloning. We reasoned that bioinformatics analysis of the re-
ference ORFs could be done at a later date (see below), and al-
though this would likely mean inclusion of some truncated clones
in the Gateway collection, this was preferable to a delay of twelve
months or more whilst bioinformatics resources were put in place
and analysis methods developed.
High ﬁdelity PCR was used to amplify putative ORFs from the
XGC clones, using the XGC reference open reading frame co-
ordinates, beginning with the start codon but omitting the stop
codon. These products were then introduced into the pDONR223
Gateway vector as described (see Section 2). The resulting Xenopus
entry clone plasmids are propagated as bacterial transformants.
We successfully cloned open reading frames from 8673 (88%) of
the 9805 clones recovered as starting material from our copy of
the XGC collection (see Section 2). This compares favourably with
both the human ORFeome, v8.1 (Yang et al., 2011), and the C.
elegans ORFeome, v1.1 (Reboul et al., 2003), with recovery rates of
84% and 62%, respectively. The median open reading frame lengths
in the successfully cloned ORFs compared to the reference ORFs in
the whole XGC collections are 1053 bp and 1080 bp, respectively.
In addition, there appears to be no signiﬁcant difference between
the two distributions of ORF lengths (Fig. 2c), indicating that
longer open reading frames are not signiﬁcantly more likely to fail
during the cloning process than shorter ones, contrary to the be-
haviour observed in a previous high throughput Gateway cloning
project (Reboul et al., 2003). Successfully cloned ORFs were con-
solidated into a new set of distribution plates. The plate map of the
Xenopus ORFeome is provided as Supplementary information Ta-
ble S1, and contains the plate and well location of each clone, its
full-length status (see below), the gene name, and other relevant
information.
3.2. Validation of Gateway transferability of Xenopus ORFeome
clones
To validate the performance of the ﬁnished Gateway entry
clones, we selected 20 clones from those which passed the quality
control tests of the Gateway cloning process, and would therefore
be part of the Xenopus ORFeome v1. These were then transferred
using standard methods from the initial Gateway entry vectors
into a pCSf107mT-Gateway-3′LAP destination vector (see Section
2). Two clones failed outright at this step, and appear not to have
inserts; these may have been deleted by the host as toxic. A third
clone contained the correct sequence, but in a mixture of other
sequences, which we were able to resolve by streaking out single
colonies and sequencing ﬁve of these: two out of ﬁve were correct.
We suggest that this may be good standard practise for handling
this material. The remaining 17 clones were veriﬁed by sequencing
to have been correctly transferred to the destination vector, and
these were then further characterized through coupled, in vitro
transcription and translation (see Section 2). Fifteen of these gave
immunoblot products of the expected molecular weight (Fig. 1e).
Given the sequence veriﬁcation, it is unclear why the other two
proteins were not correctly translated. It is possible that the pro-
tein products are degraded. We know that CenpK protein is a
subunit of a large kinetochore complex (Cenp-HIKM) anddepletion of any protein in the complex results in co-depletion of
the other subunits from kinetochores (Cheeseman et al., 2008). We
also note that Ndel1 exists in a complex, so it is possible that
production of these proteins in an inappropriate molecular en-
vironment results in their rapid degradation. Nevertheless, we
conclude that a random set of clones from the Xenopus ORFeome
could be transferred to a destination vector with a reasonable
success rate, and if our test set is representative this would be
approximately 85%. The failure of transferred clones to generate
stable protein is likely to be protein speciﬁc, and users may wish to
test that generated proteins are detectable and of the correct
molecular weight.
3.3. Gene coverage in the ORFeome
Estimating gene coverage is slightly complicated by the allo-
tetraploid nature of X. laevis. Duplicated genes (termed home-
ologs) are considered to have been orthologs of each other in the
two (presumed) ancestral diploid frogs, and are therefore both
orthologous to the equivalent single gene in the diploid X. tropi-
calis. In order to simplify discussion of gene numbers here, and
although we recognise that some of the homoleogous pairs may
have become sub-functionalized, we refer to diploid equivalent
genes, where two homeologs count as a single gene.
To determine how many diploid equivalent genes are covered
by the 8402 distinct ORFs in the Xenopus ORFeome, we used an-
notation from Xenbase. Each of the ORFs has an assigned Xenbase
gene ID, and they are divided into two groups: 6946 ORFs, within
which homeologous relationships have been identiﬁed through
curation, and 1456 ORFs where the homeologous relationships are
not known. The curated group covers 6507 (diploid equivalent)
gene loci; and from this we can estimate that the uncurated group
likely covers 1364 gene loci (assuming a similar proportion of
homeologous pairs). The whole ORFeome therefore covers an es-
timated 7871 diploid equivalent Xenopus genes, containing 531
homeologous pairs, with an additional 271 duplicated ORFs.
Although it is widely accepted that the inter-speciﬁc hy-
bridisation event giving rise to whole genome duplication in X.
laevis will likely have been followed by gene loss, it is interesting
that we only identify clones for both homeologs in ∼6.7% of the
genes on our collection. This is, however, in proportion to the total
numbers of homeologous pairs identiﬁed on Xenbase (of 12532
gene pages with at least on X. laevis gene, only 836 have two
identiﬁed homeologs), and it is not clear to what extent these
numbers simply reﬂect current annotation efforts, or whether this
tells us something more interesting about the expression of
homeologous genes. At the DNA level, a recent study found se-
parate hybridisation signals on homeologous pairs of X. laevis
chromosomes for 50/60 (80%) selected genes (Uno et al., 2013),
and direct estimates of the sizes of homeologous chromosome
pairs found that one of each pair is smaller than the other by
factors between 0.75 and 0.94 (Matsuda et al., 2015), suggesting an
approximate upper bound for gene retention if gene loss is pro-
portionate to sequence loss.
3.4. Veriﬁcation of the XGC reference ORFs
Towards the end of the physical cloning process, and as the
necessary resources became available, we performed computa-
tional analysis of the XGC reference ORFs on which the cloning
was based. Our aim was to provide a comprehensive analysis of
the ORFeome collection, giving users clear guidance as to which
clones are highly likely to contain the complete coding sequence,
and which may be truncated. Such analyses have not been pre-
viously reported for ORFeome collections of other species, but,
anecdotally, truncated clones have been observed in collections
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codon of an open reading frame in single pass sequence data from
large clone collections, and independent analysis of such data
(Gilchrist, 2012) suggests that around 10% are likely to be mis-
identiﬁed as full-length. Information on the likelihood that a given
clone is a bona ﬁde full-length clone would therefore be very
valuable.
To investigate this, we devised a series of tests of the XGC se-
quences based on three sets of data: BLASTn alignments between
the XGC reference sequences and the consensus sequences from
assembled EST contigs with annotated ORFs in a publicly available
resource (http://genomics.nimr.mrc.ac.uk/online/xt-ﬂ-db.html, as-
sembly Xl4) using methods described previously (Gilchrist et al.,
2004); BLASTx alignments between the XGC reference sequences
and complete sets of protein sequences from six non-Xenopus
species; and sequence matching between positionally-deﬁned
short sequence tags (96 bp) taken from the start of the XGC re-
ference ORF and similar tags taken from the assembled EST contigs
at successive in-frame ATGs from the ﬁrst. The assembled EST
contigs are associated with data that makes use of established full-
length scoring methods (Gilchrist et al., 2004), which have re-
cently been reﬁned, and extended with a new cliff test to de-
termine the probable start of transcription, incorporating our un-
derstanding of the likely behaviour of reverse transcriptase in
cDNA library making and its impact on EST sequence data
(Gilchrist et al., 2015). The purpose of both the BLASTn alignments
and the positional tag matching was two-fold: to identify the EST
assembly for the corresponding gene (or alternate homeolog) that
each XGC sequence belonged to, and to establish the likely posi-
tion of the XGC ORF within independently determined open
reading frames. See Section 2 for more details.
Applying our tests as described (Section 2), we annotated 7705
(88.8%) of the clones in the Xenopus ORFeome (X. laevis) as having
either full-length ORFs (7396) or ORFs which are technically in-
complete but have conserved N-terminus translated sequences
(309), starting from an in-frame, conserved ATG. The latter we
discuss in detail below, but we expect both of these groups to
generate functional proteins. The remainder of the collection is
divided into three groups: 493 (5.7%) which gave only negative
test results, and which we assume would likely generate func-
tionally impaired proteins; 144 (1.7%) which gave mixed positive
and negative indications; and 331 (3.8%) for which no tests were
either positive or negative. We refer to these outcomes as good,
conserved, bad, mixed and unknown respectively (Table 4, Fig. 2b).
The conserved, but technically not full-length, group is both
striking and interesting. These 309 clones share a common fea-
ture: the ATG codon deﬁned in the XGC reference sequence as the
start of the open reading frame corresponds to the second, or
subsequent, in-frame ATG codon in the assembled EST contig data,
and this second ATG corresponds more closely to the start of the
translated protein in a range of other species including X. tropicalis,
than the ﬁrst ATG (Fig. 3a and b). In these cases, therefore, the
normal X. laevis protein from these loci would contain a small
number of additional, non-conserved N-terminal amino acids, and
although the effect of this on the function of the protein is unclear,
it would seem likely that, in these cases, the slightly shorterTable 4
Classiﬁcation of full-length status of the ORFs in the Xenopus ORFeome.
Full-length classiﬁcation Clones in Xenopus ORFeome v1.0
Good 7396 (85.3%)
Conserved 309 (3.6%)
Bad 493 (5.7%)
Mixed 144 (1.7%)
Unknown 331 (3.8%)protein from the Gateway clone would be fully functional. In many
of these cases the XGC reference sequence contains the upstream
ATG, but this had not been identiﬁed as the start of translation; i.e.
it is located in the nominal 5′ untranslated region (UTR). We be-
lieve this may stem from the original XGC analysis which allowed
full-length prediction on single sequences using protein align-
ments from other species (Gerhard et al., 2004; Morin et al., 2006).
The merit of this approach is that it may avoid mis-prediction in
cases where an upstream in-frame ATG is introduced by non-ca-
nonical transcription start sites (Fig. 4a) or splicing, or frame-shifts
caused by sequencing or cloning errors.
In some of the cases that we studied, it was the upstream ATG
in the assembled EST contig that was unreliable, and therefore a
fault of the EST-based analysis, not the XGC prediction; this ac-
counted for at least the ﬁve most distant upstream ATGs in this
group. The distribution of the lengths of the ‘lost’ sequences
(Fig. 3c) shows that most of them are short, and in the majority
(50.5%) of cases involves a loss of ten or fewer residues.
To conﬁrm the negative analysis we inspected a number of the
clones in the bad category. These generally fell into two groups:
those where the XGC sequence contained an upstream in-frame
ATG, which either had better evidence to support the longer ORF
(Fig. 4c), or where there was insufﬁcient protein alignment evi-
dence and the longer ORF was logically correct; and those where
the XGC sequence appears to be truncated, relative to the EST
contig data, and therefore does not contain the upstream, and
probably, correct ATG (Fig. 4b). The former (and larger) group will
be rescued from the existing clones by designing new 5′ primers
where the XGC sequence contains the start of translation, in the
correct frame and position, predicted from the EST contig data. In
the interest of timely release of v1.0 of the ORFeome, this will be
done in the next stage of the project. This will also be done for full
ORFs in the conserved category described above.
The complementary situation occurs when the XGC reference
sequence has an in-frame, but apparently incorrect, ATG upstream
of the deﬁned start of the coding sequence, generated by atypical
transcription (Fig. 4a) or sequencing and cloning artefacts. In these
cases the XGC ORF prediction is likely correct, and we note that
these cases support the use of conservation as a criterion for full-
length prediction, rather than strict codon-based analysis, when
analysing single sequence data.
3.5. Recording and updating the full-length-status of clones in the
collection
The full-length status of each clone in the Xenopus ORFeome is
given both in the plate map of the collection (Supplementary In-
formation, Table S1) and in the ORFeome section of Xenbase
(www.xenbase.org/reagents/static/orfeome.jsp). The status of in-
dividual clones may change in the future as new data resources,
such as improvements in the X. laevis genome assembly, become
available, or as analysis methods are further reﬁned. Data sources
will be updated periodically to reﬂect this: new plate maps will be
issued with releases of future versions of the ORFeome, or to co-
incide with signiﬁcant improvements in analysis techniques, and
data will be updated on Xenbase as frequently as feasible. We
suggest that potential users of this resource carefully explore the
underlying reference data for their clones of interest, especially
where the analysis is ambiguous. In this context it may be im-
portant to bear in mind that some X. laevis proteins found in public
repositories are likely to have been deﬁned from the XGC re-
ference sequence, and we suggest that this data on its own may be
insufﬁcient to establish the veracity of the published ORF. Users
are welcome to send us evidence for clones they consider to have
been wrongly classiﬁed, and we will modify our records where
appropriate.
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Fig. 3. Truncated but conserved ORFS. Examples of genes where the open reading frame in X. laevis is slightly longer than in other species, including X. tropicalis, suggesting that
the shorter ORFeome clone, based on the XGC predicted ORF, is conserved and likely to be functional. Sections of EST clusters showing aligned nucleotide sequences (ESTs) with in-
frame stop and ATG codons in red and green respectively. ORF predicted from aligned EST codons is in purple. Start of the XGC reference ORF is indicated by arrow. Protein
alignments are shown above in turquoise, with the leftmost ‘P’ being the predicted relative position of the N-terminal end of these proteins. (a) The extremely highly conserved
N-terminus of histamine N-methyl transferase is extended by 15 bp. (b) The moderately conserved N-terminus of platelet-activating factor receptor is extended by 6 bp compared to
Xenopus tropicalis, and both are longer then the chick, human, mouse and zebraﬁsh proteins. Note the erroneous prediction for the Xenopus laevis protein in both cases.
(c) Distribution of the numbers of lost N-terminal residues between the shorter, conserved XGC reference ORFs and the longer true ORFs in Xenopus laevis.
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Fig. 4. Example alignments of XGC cDNA sequences and matching EST clusters. (a) Brain and reproductive organ-expressed protein (TNFRSF1A), illustrating divergence be-
tween the XGC sequence and the cluster consensus sequence, and adding 60 bp to an upstream ATG. Genomic alignment indicates (data not shown) this to be a non-
canonical exon; we note that the XGC prediction was for the canonical start of translation. (b) CWF19-like 2, cell cycle control (cwf19l2), illustrating 5′ truncation of the cDNA
sequence (i.e. the ORF and 5′ UTR). The EST cluster and conserved homologous peptide sequences contain additional sequence that is not present in the 5′ UTR of the XGC
clone. Some interposing sequence is not shown; the numbered, horizontal scale has been clipped and compressed for clarity. (c) Lymphocyte cytosolic protein 1 (L-plastin),
illustrating a 5′ truncated XGC ORF due to erroneous identiﬁcation of the correct start codon. In this case, the 5′ UTR of the XGC cDNA contains the extra matching coding
sequence from the EST cluster, and is supported by matching alignment of conserved homologous peptide sequence from non-Xenopus species.
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To facilitate the use of the Xenopus ORFeome resource in ex-
periments aimed at modelling human disease in Xenopus, we have
identiﬁed those genes in the collection whose human orthologs
are, either directly or indirectly, implicated in disease; these may
also prove useful starting points for functional investigation. To do
this we used two sets of human gene–disease association data: the
ﬁrst set was taken from OMIM (http://omim.org) which we count
as primary or direct gene–disease associations; the second set was
taken from published data (Lage et al., 2008), incorporating OMIM
disease genes but extending the disease association to other genes
whose proteins are predicted to be in physical complexes (derived
from protein interaction data) with OMIM entries, which we count
as indirect gene–disease associations. Direct and indirect disease
associations are reported in separate columns in the supplemen-
tary data ﬁle (Supplementary information, Table S2).
To link the human disease genes to our Xenopus Gateway
clones we used the Xenopus–human orthology data available in
Xenbase (see Section 2). This also gives us a general estimate of the
coverage of human genes within the Xenopus ORFeome v1.0,
identifying human orthologs for 80% (6940) of the clones, corre-
sponding to approximately 29% of human protein-coding genes.
Combining the direct and indirect disease associations, we have
identiﬁed 3048 clones in our collection, covering 2724 Xenopus
orthologs of human genes associated with a total of 2030 different
disease disorders (see Supplementary information, Table S2). Of
the 2030 human diseases, 1501 (75%) were linked by a direct as-
sociation to an ORFeome clone, with the remaining 529 having
one or more indirect associations. Looking more closely at the
coverage of the 1524 complexes deﬁned in the protein interaction
data (Lage et al., 2008), we found one or more Xenopus ORFeome
genes, with a direct or indirect association, in 1349 complexes,
covering 974 disease conditions. For 72 of those complexes, all the
genes from the complex are present as orthologs in the ORFeome.
This high coverage serves to validate the Xenopus ORFeome as an
invaluable tool for probing the mechanisms underlying many
human diseases using the Xenopus model system.
3.7. Release and distribution of the Xenopus ORFeome clones and
associated plasmids
The Xenopus ORFeome collection is released as of the date of
writing. Information on the ORFeome collection including quality
assessments of the full-length clones and ordering information is
available at Xenbase (www.xenbase.org/reagents/static/orfeome.
jsp). To maximise availability to the community we have provided
complete sets of plates to a number of distributors, both com-
mercial and not-for-proﬁt. These currently include: Source
Bioscience (www.sourcebioscience.com), GE Healthcare–GE Life-
sciences/Dharmacon (dharmacon.gelifesciences.com), DNASU
Plasmid Repository at the ASU Biodesign Institute (dnasu.org/
DNASU/Home.do), Dana-Farber/Harvard Cancer Centre DNA Re-
source Core (dnaseq.med.harvard.edu), and The European Xenopus
Resource Centre (EXRC) (www.port.ac.uk/research/exrc). Some of
these (e.g. EXRC) may only distribute small numbers of individual
clones. In addition Xenbase hosts a search facility under Reagents
and Protocols tab for ﬁnding ORFeome clones (www.xenbase.org/
reagents/orf.do), and users will ﬁnd links to clones on individual
gene pages.
A large number of destination vectors are already available to
researchers; we have generated three vectors for the Xenopus
community based on pCSf107mT, which has a pCS2 backbone and
three tandem SP6 stop sequences, circumventing the need to line-
arise the plasmid when transcribing in vitro (Mii and Taira, 2009).
The generation of pCSf107mT-Gateway-3′LAP Tag is given in Section2; similar methods were used to generate pCSf107mT-Gateway-3′
MycTag, pCSf107mT-Gateway-3′HA Tag, and pCSf107mT-Gateway-
3′Flag Tag vectors. To increase the accessibility of these four con-
structs we have submitted them as plasmids to Addgene (www.
addgene.org), where they will be available in the normal way (the
relevant Addgene IDs are: 67616, 67617, 67618 and 67619). They are
currently also available through the EXRC at Portsmouth, UK.4. Conclusions
We have generated v1.0 of the Xenopus ORFeome within the
Gateway recombination cloning system, using 8673 pre-existing X.
laevis cDNA clones from the Xenopus Gene Collection, and covering
an estimated 7871 unique genes. Presented in Gateway entry
vectors (pDONR223), they are available to the community to buy
as a complete set of 93, 96-well plates, or as individual clones. The
Xenopus ORFeome resource will be supported on Xenbase.org, the
Xenopusmodel organism database; providing links to vendors, and
to sources of community developed Gateway destination vectors.
Links to ORFeome clones will be found on gene pages, and users
can search for clones on the Xenbase ORFeome project page
(http://www.xenbase.org/reagents/static/orfeome.jsp), or by
BLAST via the gene pages. Each clone has a dedicated page, in-
cluding NCBI Entrez and RefSeq IDs, the XGC template, PCR pri-
mers used to amplify the ORF, and its full-length status (Fig. 5),
integrated into Xenbase, alongside other genomic, expression,
function and human disease model metadata relevant to each ORF.
The bioinformatic analysis of each clone forms a distinctive
component of the Xenopus ORFeome: the summary status of each
clone is given, the reasoning behind which can be deduced from
the individual test scores. This will signiﬁcantly increase the utility
of the collection, and, to the best of our knowledge, is unique
amongst ORFeomes. We recommend that users note the full-
length status of their clone(s) of interest, and also check the as-
sociated reference sequence, especially where our full-length
conﬁdence is moderate or low. Version 2.0 of the Xenopus OR-
Feome will use the bioinformatic analysis up front to exclude
clearly problematic clones, whilst continuing to include conserved
clones, and those where analysis remains unclear.
This version 1.0 of the Xenopus ORFeome covers nearly 40% of
the X. laevis proteome, and currently represents the third largest
ORFeome behind the human and C. elegans projects. The next re-
lease of the Xenopus ORFeome will extend gene coverage by in-
cluding clones from two X. tropicalis EST collections (Gilchrist et al.,
2004; Klein et al., 2002). The second phase of the project will
generate Gateway clones by PCR of missed and computationally
deﬁned ORFs from suitable cDNA libraries.
The experimental advantages of Xenopus have been used for
decades to discover fundamental mechanisms of cell and devel-
opmental biology. The recent sequencing of the two Xenopus
genomes has shown a remarkable similarity with the human
genome, including the Xenopus orthologs of many human disease
genes (Hellsten et al., 2010). The high degree of anatomical simi-
larity, and the ability to easily perform both gain- and loss-of-
function studies, makes Xenopus ideally suited to studying gene
function in models of human disease. Recent examples of the ef-
fectiveness of this approach include cancer (Chernet and Levin,
2013), wound healing (Soto et al., 2013), congenital heart disease
(Fakhro et al., 2011), and epilepsy (Bell et al., 2011). Coupled with
the rapid and cost effective functional genomics possible in this
system, the Xenopus ORFeome collection will greatly facilitate a
mechanistic analysis of the proteome and accelerate our under-
standing of human disease.
Fig. 5. Example screenshot of a web page on Xenbase.org for Xenopus ORFeome clone (for Kif2c ORF1), illustrating metadata information such as associated IDs, plate & well
location, links to vendors, coding sequence, full-length quality indication, and XGC template cDNA source information.
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